IP Library › Granted Patent US 11,352,418
Granted Patent B2
US 11,352,418 · App. 16/508,991 · Granted Jun 7, 2022

Analysis of ubiquitinated polypeptides

Inventors: Michael J. Comb (Manchester, MA); John Edward Rush, II (Beverly, MA); Jing Li (Brighton, MA); Ailan Guo (Lexington, MA)
Assignee: CELL SIGNALING TECHNOLOGY, INC.
C07K16/18C07K2317/24C07K2317/34C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,352,418
App. No.
16/508,991
Granted
Jun 7, 2022
Kind
B2
Abstract

The disclosure relates to antibody reagents that specifically bind to peptides carrying a ubiquitin remnant from a digested or chemically treated biological sample. The reagents allow the technician to identify ubiquitinated polypeptides as well as the sites of ubiquitination on them. The reagents are preferably employed in proteomic analysis using mass spectrometry. The antibody reagents specifically bind to the remnant of ubiquitin (i.e., a diglycine modified epsilon amine of lysine) left on a peptide which as been generated by digesting or chemically treating ubiquitinated proteins. The inventive antibody reagents' affinity to the ubiquitin remnant does not depend on the remaining amino acid sequences flanking the modified (i.e., ubiquitinated) lysine, i.e., they are context independent.

Claims (12)

1. A method of isolating peptides comprising lysine residues having a ubiquitin remnant comprising:

(a) digesting a sample of proteins with a hydrolyzing agent to produce a mixture of cleavage peptides;

(b) contacting the mixture of cleavage peptides with an antibody or a specific binding fragment thereof that specifically binds a ubiquitin remnant, wherein the antibody or specific binding fragment thereof comprising a heavy chain CDR1 as set forth in SEQ ID NO:3, a heavy chain CDR2 as set forth in SEQ ID NO:4, a heavy chain CDR3 as set forth in SEQ ID NO:5, a light chain CDR1 as set forth in SEQ ID NO:6, a light chain CDR2 as set forth in SEQ ID NO: 7, and a light chain CDR3 as set forth in SEQ ID NO:8;

(c) eluting cleavage peptides that have specifically bound to the antibody or specific binding fragment thereof; and

(d) purifying the cleavage peptides, such that peptides comprising lysine residues having a ubiquitin remnant are detected.

2. The method of claim 1 , wherein the proteins are a suspension of cells, a subcellular fraction of a cell line or tissue, or a cellular lysate.

3. The method of claim 1 , wherein the hydrolyzing agent is a protease.

4. The method of claim 3 , wherein the protease is trypsin.

5. The method of claim 1 , wherein the antibody or specific binding fragment thereof is linked to a bead, polystyrene matrix, protein G agarose beads, agarose gel matrix, or nitrocellulose membrane.

6. The method of claim 1 , wherein the antibody or specific binding fragment thereof is linked to an agarose bead.

7. The method of claim 1 , wherein the cleavage peptides are purified by HPLC or reversed phase liquid chromatography.

8. The method of claim 1 , wherein after the cleavage peptides are purified they are subjected to liquid chromatography MS/MS analysis.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF THE FIRST INVENTORS NAME PREVIOUSLY RECORDED AT REEL: 051802 FRAME: 0045. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 19, 2020
From: RUSH, JOHN EDWARD, II; LI, JUNG; GUO, ALIAN; COMB, MICHAEL J.
To: CELL SIGNALING TECHNOLOGY, INC.
Reel/Frame 053560/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2020
From: RUSH, JOHN EDWARD, III; LI, JING; GUO, ALIAN; COMB, MICHAEL J
To: CELL SIGNALING TECHNOLOGY, INC.
Reel/Frame 051802/0045 →
Continuity (6)
Continuation 14572194 · Dec 16, 2014
Continuation In Part 13856933 · Apr 4, 2013
Division 12967284 · Dec 14, 2010
Continuation In Part 11484485 · Jul 11, 2006
Provisional Application 61286486 · Dec 15, 2009
Related Publication 20200131254A1 · Apr 30, 2020